Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 32023R1143

    Commission Implementing Regulation (EU) 2023/1143 of 9 June 2023 granting a Union authorisation for the single biocidal product ‘Chemisept IPA-N’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

    C/2023/3685

    OJ L 151, 12.6.2023, p. 11–19 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    Legal status of the document In force

    ELI: http://data.europa.eu/eli/reg_impl/2023/1143/oj

    12.6.2023   

    EN

    Official Journal of the European Union

    L 151/11


    COMMISSION IMPLEMENTING REGULATION (EU) 2023/1143

    of 9 June 2023

    granting a Union authorisation for the single biocidal product ‘Chemisept IPA-N’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

    (Text with EEA relevance)

    THE EUROPEAN COMMISSION,

    Having regard to the Treaty on the Functioning of the European Union,

    Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 44(5), first subparagraph, thereof,

    Whereas:

    (1)

    On 24 April 2019, AS Chemi-Pharm submitted to the European Chemicals Agency (‘the Agency’) an application in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013 (2) for authorisation of the same single biocidal product, as referred to in Article 1 of that Regulation, named ‘Chemisept IPA-N’, of product-type 1, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-UU051173-14 in the Register for Biocidal Products (‘the Register’). The application also indicated the application number of the related reference biocidal product family ‘Knieler & Team Propanol Family’, recorded in the Register under case number BC-AQ050985-22.

    (2)

    The same single biocidal product ‘Chemisept IPA-N’ contains propan-1-ol and propan-2-ol as the active substances, which are included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012 for product-type 1.

    (3)

    On 8 December 2021, the Agency submitted to the Commission an opinion (3) and the draft summary of the biocidal product characteristics (‘SPC’) of ‘Chemisept IPA-N’ in accordance with Article 6 of Implementing Regulation (EU) No 414/2013.

    (4)

    The opinion concludes that the proposed differences between the same single biocidal product and the related reference biocidal product are limited to information which can be the subject of an administrative change in accordance with Commission Implementing Regulation (EU) No 354/2013 (4), and that based on the assessment of the related reference biocidal product family ‘Knieler & Team Propanol Family’ and subject to compliance with the draft SPC, the same single biocidal product meets the conditions laid down in Article 19(1) of Regulation (EU) No 528/2012.

    (5)

    On 24 October 2022, the Agency transmitted to the Commission the draft SPC in all the official languages of the Union in accordance with Article 44(4) of Regulation (EU) No 528/2012.

    (6)

    The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for the same single biocidal product ‘Chemisept IPA-N’.

    (7)

    The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,

    HAS ADOPTED THIS REGULATION:

    Article 1

    A Union authorisation with authorisation number EU-0027678-0000 is granted to AS Chemi-Pharm for the making available on the market and use of the same single biocidal product ‘Chemisept IPA-N’ in accordance with the summary of the biocidal product characteristics set out in the Annex.

    The Union authorisation is valid from 2 July 2023 until 31 July 2032.

    Article 2

    This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

    This Regulation shall be binding in its entirety and directly applicable in all Member States.

    Done at Brussels, 9 June 2023.

    For the Commission

    The President

    Ursula VON DER LEYEN


    (1)   OJ L 167, 27.6.2012, p. 1.

    (2)  Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4).

    (3)  ECHA opinion for ‘Chemisept IPA-N’, 8 December 2021, https://echa.europa.eu/opinions-on-union-authorisation

    (4)  Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p. 4).


    ANNEX

    Summary of product characteristics for a biocidal product

    Chemisept IPA-N

    Product type 1 – Human hygiene (Disinfectants)

    Authorisation number: EU-0027678-0000

    R4BP asset number: EU-0027678-0000

    1.   ADMINISTRATIVE INFORMATION

    1.1.   Trade name(s) of the product

    Trade name(s)

    Chemisept IPA-N

    1.2.   Authorisation holder

    Name and address of the authorisation holder

    Name

    Chemi-Pharm AS

    Address

    Tänassilma tee 11, 76406 Tänassilma küla, Saku vald Estonia

    Authorisation number

    EU-0027678-0000

    R4BP asset number

    EU-0027678-0000

    Date of the authorisation

    2.7.2023

    Expiry date of the authorisation

    31.7.2032

    1.3.   Manufacturer(s) of the product

    Name of manufacturer

    AS Chemi-Pharm

    Address of manufacturer

    Tänassilma tee 11, 76406 Tänassilma küla, Saku vald, Harju maakond Estonia

    Location of manufacturing sites

    AS Chemi-Pharm, Tänassilma tee 11, 76406 Tänassilma küla, Saku vald, Harju maakond Estonia

    1.4.   Manufacturer(s) of the active substance(s)

    Active substance

    Propan-1-ol

    Name of manufacturer

    OQ Chemicals GmbH (formerly Oxea GmbH)

    Address of manufacturer

    Rheinpromenade 4a, 40789 Monheim am Rhein Germany

    Location of manufacturing sites

    OQ Chemicals Corperation (formerly Oxea Coperation), 2001 FM 3057 TX, 77414 Bay City United States


    Active substance

    Propan-1-ol

    Name of manufacturer

    BASF SE

    Address of manufacturer

    Carl-Bosch-Str. 38, 67056 Ludwigshafen Germany

    Location of manufacturing sites

    BASF SE, Carl-Bosch-Str. 38, 67056 Ludwigshafen Germany


    Active substance

    Propan-1-ol

    Name of manufacturer

    SASOL Chemie GmbH & Co. KG

    Address of manufacturer

    Secunda Chemical Operations, Sasol Place, 50 Katherine Street, 2090 Sandton South Africa

    Location of manufacturing sites

    Secunda Chemical Operations, PDP Kruger Street, 2302 Secunda South Africa


    Active substance

    Propan-2-ol

    Name of manufacturer

    INEOS Solvent Germany GmbH

    Address of manufacturer

    Römerstrasse 733, 47443 Moers Germany

    Location of manufacturing sites

    INEOS Solvent Germany GmbH, Römerstrasse 733, 47443 Moers Germany

    INEOS Solvent Germany GmbH, Shamrockstrasse 88, 44623 Herne Germany

    2.   PRODUCT COMPOSITION AND FORMULATION

    2.1.   Qualitative and quantitative information on the composition of the product

    Common name

    IUPAC name

    Function

    CAS number

    EC number

    Content (%)

    Propan-1-ol

     

    Active Substance

    71-23-8

    200-746-9

    30,0

    Propan-2-ol

     

    Active Substance

    67-63-0

    200-661-7

    45,0

    2.2.   Type of formulation

    AL – Any other liquid

    3.   HAZARD AND PRECAUTIONARY STATEMENTS

    Hazard statements

    Flammable liquid and vapour.

    Causes serious eye damage.

    May cause drowsiness or dizziness.

    Repeated exposure may cause skin dryness or cracking.

    Precautionary statements

    Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. – No smoking.

    Keep container tightly closed.

    Avoid breathing vapours.

    Use only outdoors or in a well-ventilated area.

    IF INHALED:Remove person to fresh air and keep comfortable for breathing.

    IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing.

    Immediately call a POISON CENTER/doctor.

    Store in a well-ventilated place.Keep cool.

    Store locked up.

    Dispose of container to an authorised waste collection point.

    4.   AUTHORISED USE(S)

    4.1.   Use description

    Table 1

    Use # 1 – hygienic handrub, liquid

    Product type

    PT01 – Human hygiene (Disinfectants)

    Where relevant, an exact description of the authorised use

    Not relevant

    Target organism(s) (including development stage)

    Scientific name: no data

    Common name: Bacteria

    Development stage: no data

    Scientific name: no data

    Common name: Mycobacteria

    Development stage: no data

    Scientific name: no data

    Common name: Yeasts

    Development stage: no data

    Scientific name: no data

    Common name: Enveloped viruses

    Development stage: no data

    Field(s) of use

    Indoor

    hospitals and other health care institutions, ambulances, surgeries, nursing homes (including home-care of patients)

    hospital canteens, large kitchens, pharmaceutical industries, production sites, laboratories: hygienic handrub onto visibly clean and dry hands

    for professional use only

    Application method(s)

    Method: Manual application

    Detailed description:

    Rubbing

    Application rate(s) and frequency

    Application Rate: Dosage: At least 3 ml (use dispensers: for example set to 1,5 ml per stroke, 2 strokes per 3 ml) Contact time: 30 s

    Dilution (%): Ready-to-use product

    Number and timing of application:

    There is no restriction in the number and timing of applications. No safety intervals need to be considered between the application phases.

    The product may be used at any time and as often as required.

    Category(ies) of users

    Industrial

    Professional

    Pack sizes and packaging material

    100, 125, 500, 1 000 ml in transparent/white high-density polyethylene (HDPE) bottles with polypropylene (PP) flip top caps;

    5 000 ml transparent/white HDPE canister with HDPE screwed cap.

    4.1.1.   Use-specific instructions for use

    The products can be applied directly or the products can be used in a dispenser or with a pump.

    For hygienic handrub use 3 ml of product and keep hands wet for 30 seconds.

    Do not refill.

    4.1.2.   Use-specific risk mitigation measures

    See general directions for use.

    4.1.3.   Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment

    See general directions for use.

    4.1.4.   Where specific to the use, the instructions for safe disposal of the product and its packaging

    See general directions for use.

    4.1.5.   Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage

    See general directions for use.

    4.2.   Use description

    Table 2

    Use # 2 – surgical handrub, liquid

    Product type

    PT01 – Human hygiene (Disinfectants)

    Where relevant, an exact description of the authorised use

    Not relevant

    Target organism(s) (including development stage)

    Scientific name: no data

    Common name: Bacteria

    Development stage: no data

    Scientific name: no data

    Common name: Mycobacteria

    Development stage: no data

    Scientific name: no data

    Common name: Yeasts

    Development stage: no data

    Scientific name: no data

    Common name: enveloped viruses

    Development stage: no data

    Field(s) of use

    Indoor

    Hospitals and other health care institutions: surgical handrub onto visibly clean and dry hands and forearms.

    For professional use only.

    Application method(s)

    Method: Manual application

    Detailed description:

    Rubbing

    Application rate(s) and frequency

    Application Rate: Dosage: Rub sufficient amount in portions of 3 ml (use dispensers: for example set to 1,5 ml per stroke, 2 strokes per 3 ml). Contact time: 90 s

    Dilution (%): Ready-to-use product

    Number and timing of application:

    There is no restriction in the number and timing of applications. No safety intervals need to be considered between the application phases.

    The product may be used at any time and as often as required.

    Category(ies) of users

    Professional

    Pack sizes and packaging material

    100, 125, 500, 1 000 ml in transparent/white high-density polyethylene (HDPE) bottles with polypropylene (PP) flip top caps;

    5 000 ml transparent/white HDPE canister with HDPE screwed cap.

    4.2.1.   Use-specific instructions for use

    The products can be applied directly or the products can be used in a dispenser or with a pump.

    For surgical handrub use as many portions of 3 ml as necessary to keep hands wet for 90 seconds.

    Do not refill.

    4.2.2.   Use-specific risk mitigation measures

    See general directions for use.

    4.2.3.   Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment

    See general directions for use.

    4.2.4.   Where specific to the use, the instructions for safe disposal of the product and its packaging

    See general directions for use.

    4.2.5.   Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage

    See general directions for use.

    5.   GENERAL DIRECTIONS FOR USE (1)

    5.1.   Instructions for use

    For professional use only.

    5.2.   Risk mitigation measures

    Avoid contact with eyes.

    Keep out of reach of children.

    5.3.   Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment

    First-aid measures general: Move the affected person away from the contaminated area. Get medical advice/attention if you feel unwell. If possible, show this sheet.

    IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTRE or a doctor.

    IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor.

    IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance.

    Information to Healthcare personnel/doctor:

    The eyes should also be rinsed repeatedly on the way to the doctor if eye exposure to alkaline chemicals (pH > 11), amines and acids like acetic acid, formic acid or propionic acid.

    IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance.

    Accidental release measures:

    Stop leak if safe to do so. Remove ignition sources. Use special care to avoid static electric charges. No open flames. No smoking.

    Prevent entry to sewers and public waters.

    Wipe up with absorbent material (for example cloth). Soak up spills with inert solids, such as clay or diatomaceous earth as soon as possible. Take up mechanically (sweeping, shovelling). Dispose of in accordance with relevant local regulations.

    5.4.   Instructions for safe disposal of the product and its packaging

    Disposal must be done according to official regulations. Do not empty into drains. Do not dispose of with domestic waste. Dispose of contents/container to an authorised waste collection point. Empty the packaging completely prior to disposal. When totally empty, containers are recyclable like any other packing.

    5.5.   Conditions of storage and shelf-life of the product under normal conditions of storage

    Shelf-life: 24 months

    Store in dry, cool, well-ventilated area. Keep container tightly closed. Keep out of direct sunlight.

    Recommended storage temperature: 0– 30 °C

    Do not store at temperatures below 0 °C

    Do not store near food, drink and animal feedingstuff. Keep away from combustible material.

    6.   OTHER INFORMATION


    (1)  Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses.


    Top